We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Final Guidance on Drugs for Hay Fever, Non-Allergic Rhinitis
FDA Releases Final Guidance on Drugs for Hay Fever, Non-Allergic Rhinitis
The FDA issued new guidance for sponsors of drugs designed to treat hay fever as well as other cold-like symptoms that aren’t caused by allergies. In a pair of final guidances, the agency urges drug sponsors to focus on real-world settings when trying to determine doses.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor